Local leukemia researcher picks up prestigious award

By Cai Wenjun | May 18, 2015, Monday |

Online Edition

A local researcher responsible for a leukemia breakthrough received the highest natural science award at the Shanghai Science and Technology Awards today.

Chen Saijuan and her team from Ruijing Hospital discovered a series of new molecular targets in the treatment of leukemia. The discovery made acute promyelocytic leukemia (APL) the first curable leukemia.

Doctors said APL has a high mortality rate, but Chen’s therapy has made it possible for patients to recover from the disease.

“The therapy for APL is called the ‘Shanghai Scheme” and it’s widely recognized in the world and used in many international blood centers and hospitals,” said Chen, whose team is focused on TCM treatment for leukemia through modern technology.

“I was thanked by an Italian patient when I attended a medical forum in Rome in 2009. The patient recovered from APL by the Shanghai Scheme,” Chen added. “His doctor told him Chinese doctors had invented the treatment. He asked his doctor, who also was at the forum, to give me the card to express his gratitude. It is such a great joy for me and my team.”

A total of 287 people and projects picked up awards.

Mohanmad Sawan from Canada, Chen Hongyu from the United States and Gilles Mailhot from France were honored for their contribution to international technology cooperation.

Almost 60 percent of the awards went to three industries — biology and medicine, information technology, as well as energy and environment — according to officials from the Shanghai Science and Technology Commission.

Metro

About Us
|
Terms of Use
|
RSS
|
Privacy Policy
|
Contact Us
|
Shanghai Call Center: 962288
|
Tip-off hotline: 52920043

沪ICP证：沪ICP备05050403号-1
|
互联网新闻信息服务许可证：31120180004
|
网络视听许可证：0909346
|
广播电视节目制作许可证：沪字第354号
|
增值电信业务经营许可证：沪B2-20120012

Local leukemia researcher picks up prestigious award

Email this to your friend